The one-year average price target for FibroBiologics (FBLG) was revised to $81.60/share, a 1,584.21% increase from the prior $4.84 target dated March 25, 2026. The figure is an average of multiple analysts' targets, representing a substantial repricing of analyst expectations and likely to materially affect investor sentiment and the stock's near-term valuation.
The one-year average price target for FibroBiologics (FBLG) was revised to $81.60/share, a 1,584.21% increase from the prior $4.84 target dated March 25, 2026. The figure is an average of multiple analysts' targets, representing a substantial repricing of analyst expectations and likely to materially affect investor sentiment and the stock's near-term valuation.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
